Yesintek

Yesintek (ustekinumab) is a biologic medication used for immune-mediated conditions. This biosimilar offers a subcutaneous option for adults and children managing chronic inflammatory diseases. Suitable for patients seeking targeted therapy with proven efficacy.

Ustekinumab is primarily used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and Crohn’s disease in adults. It is also indicated for ulcerative colitis in adults and pediatric patients aged 6 and older. This medication helps reduce inflammation and manage symptoms when other treatments are ineffective.

Many patients experience reduced skin lesions and joint pain after starting ustekinumab. Some notice improved mobility and fewer flare-ups of their condition over time. Individual responses vary, and benefits typically become noticeable within a few weeks of consistent use.

Store ustekinumab in the refrigerator until ready to use, avoiding freezing or exposure to heat. Keep the medication in its original packaging to protect it from light. Always check the solution for particles or discoloration before injecting. Discard any unused portion properly.

Ustekinumab may interact with live vaccines, which should be avoided during treatment. Caution is advised when combining with other immunosuppressants, as effects on the immune system could be compounded. Consult a healthcare provider before starting new medications or vaccines.